Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report) shares were up 6.3% on Friday . The company traded as high as $1.60 and last traded at $1.53. Approximately 208,423 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 450,170 shares. The stock had previously closed at $1.44.
Clearmind Medicine Trading Up 6.3 %
The business has a 50 day moving average of $1.40 and a two-hundred day moving average of $1.41. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.01.
About Clearmind Medicine
Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.
Further Reading
- Five stocks we like better than Clearmind Medicine
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is the Nasdaq? Complete Overview with History
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Upcoming IPO Stock Lockup Period, Explained
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
